---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-021947"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T00:49:47.824410+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Cencora raises FY2025 adjusted EPS guidance range by $0.05 to $15.30-$15.60

## Summary
- Guidance increase driven by continued momentum in U.S. Healthcare Solutions segment during Q2 2025.
- No change to expectations for recently completed Retina Consultants of America acquisition.
- Adjusted diluted EPS excludes acquisition intangibles, LIFO, litigation, and other items.
- Company presented updated guidance at Leerink Partners Global Healthcare Conference on March 10, 2025.

## SEC filing metadata
- accession: 0001104659-25-021947
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000110465925021947/0001104659-25-021947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000110465925021947/tm258653d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-021947
- JSON: https://secwatch.observer/filing/0001104659-25-021947.json
- Plain text: https://secwatch.observer/filing/0001104659-25-021947.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.